A new start after 60: ‘I gave up marijuana after a lifetime of smoking – and began to dream again’

Jodie Sharp’s days were all broken up the same way. “I smoked to go to work, smoked to do the washing-up, smoked for chill time.” Smoking marijuana “was a totally regular habit and every time I did it, I was smoking in exactly the same way, getting the same experience all over again.”

Sharp used a little metal pipe, and she often ran her tongue over the hard skin on her lip where the pipe sat. Her lungs hurt, her gums bled. She slept poorly and had no dream function. “I thought, ‘This is crazy. Why am I doing this at this time of my life?’”

 

Read Jodie’s story here, published by The Guardian: https://www.theguardian.com/lifeandstyle/2022/apr/11/a-new-start-after-60-i-gave-up-marijuana-after-a-lifetime-of-smoking-and-began-to-dream-again?CMP=oth_b-aplnews_d-1

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top